OBJECTIVE: To examine the extent to which a common genetic pathway is also involved in the relationship between depressive symptoms, in the absence of major depressive disorder (MDD), and inflammation. Recent data suggested that MDD and inflammation share common genes. METHODS: We recruited 188 male twins from the Vietnam Era Twin Registry who were free of symptomatic coronary artery disease and MDD, with mean +/- standard deviation (SD) age of 55 +/- 2.75 years, including 54 monozygotic and 40 dizygotic twin pairs. These pairs were assessed for two inflammatory markers, interleukin (IL)-6 and C-reactive protein (CRP). Current depressive symptoms were measured with the Beck Depression Inventory-II. Generalized estimating equations were used to examine the phenotypic association between depression and inflammatory markers. Biometrical genetic modeling was performed to estimate the genetic and environmental contributions to this association. RESULTS: An association was observed between severity of current depressive symptoms and increased levels of inflammatory markers (p < .001 for IL-6 and p = .005 for CRP). After adjustment for other factors, the association was slightly attenuated but remained statistically significant for IL-6 (p = .002). The heritability of IL-6, CRP, and depressive symptoms were estimated as 0.37, 0.65, and 0.48, respectively. Genetic modeling found a significant genetic correlation between IL-6 and depressive symptoms (r(G) = 0.22, p = .046), indicating that about 66% of the covariance between them can be explained by shared genetic influences. CONCLUSIONS: Current depressive symptoms are significantly correlated with inflammatory markers. This covariation is due, in large part, to genes that are common to depressive symptoms and inflammation.
OBJECTIVE: To examine the extent to which a common genetic pathway is also involved in the relationship between depressive symptoms, in the absence of major depressive disorder (MDD), and inflammation. Recent data suggested that MDD and inflammation share common genes. METHODS: We recruited 188 male twins from the Vietnam Era Twin Registry who were free of symptomatic coronary artery disease and MDD, with mean +/- standard deviation (SD) age of 55 +/- 2.75 years, including 54 monozygotic and 40 dizygotic twin pairs. These pairs were assessed for two inflammatory markers, interleukin (IL)-6 and C-reactive protein (CRP). Current depressive symptoms were measured with the Beck Depression Inventory-II. Generalized estimating equations were used to examine the phenotypic association between depression and inflammatory markers. Biometrical genetic modeling was performed to estimate the genetic and environmental contributions to this association. RESULTS: An association was observed between severity of current depressive symptoms and increased levels of inflammatory markers (p < .001 for IL-6 and p = .005 for CRP). After adjustment for other factors, the association was slightly attenuated but remained statistically significant for IL-6 (p = .002). The heritability of IL-6, CRP, and depressive symptoms were estimated as 0.37, 0.65, and 0.48, respectively. Genetic modeling found a significant genetic correlation between IL-6 and depressive symptoms (r(G) = 0.22, p = .046), indicating that about 66% of the covariance between them can be explained by shared genetic influences. CONCLUSIONS: Current depressive symptoms are significantly correlated with inflammatory markers. This covariation is due, in large part, to genes that are common to depressive symptoms and inflammation.
Authors: Gregory E Miller; Cinnamon A Stetler; Robert M Carney; Kenneth E Freedland; William A Banks Journal: Am J Cardiol Date: 2002-12-15 Impact factor: 2.778
Authors: J S Pankow; A R Folsom; M Cushman; I B Borecki; P N Hopkins; J H Eckfeldt; R P Tracy Journal: Atherosclerosis Date: 2001-02-15 Impact factor: 5.162
Authors: D L Musselman; U M Marzec; A Manatunga; S Penna; A Reemsnyder; B T Knight; A Baron; S R Hanson; C B Nemeroff Journal: Arch Gen Psychiatry Date: 2000-09
Authors: R M Carney; J A Blumenthal; P K Stein; L Watkins; D Catellier; L F Berkman; S M Czajkowski; C O'Connor; P H Stone; K E Freedland Journal: Circulation Date: 2001-10-23 Impact factor: 29.690
Authors: Willem J Kop; John S Gottdiener; Catherine M Tangen; Linda P Fried; Mary Ann McBurnie; Jeremy Walston; Anne Newman; Calvin Hirsch; Russell P Tracy Journal: Am J Cardiol Date: 2002-02-15 Impact factor: 2.778
Authors: Henning Tiemeier; Albert Hofman; H Ruud van Tuijl; Amanda J Kiliaan; John Meijer; Monique M B Breteler Journal: Epidemiology Date: 2003-01 Impact factor: 4.822
Authors: Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne Journal: Brain Behav Immun Date: 2018-06-19 Impact factor: 7.217
Authors: Lena M O'Keefe; Sarah J Doran; Laetitia Mwilambwe-Tshilobo; Lisa H Conti; Venugopal R Venna; Louise D McCullough Journal: Behav Brain Res Date: 2013-11-05 Impact factor: 3.332
Authors: Brandon R Grossardt; James H Bower; Yonas E Geda; Robert C Colligan; Walter A Rocca Journal: Psychosom Med Date: 2009-03-25 Impact factor: 4.312
Authors: Krassimira A Garbett; Andrea Vereczkei; Sára Kálmán; Jacquelyn A Brown; Warren D Taylor; Gábor Faludi; Željka Korade; Richard C Shelton; Károly Mirnics Journal: Biol Psychiatry Date: 2014-06-02 Impact factor: 13.382